Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Wound drainage measurements: a narrative review.
Shih T, Park S, Thorlacius LR, Daveluy S, Garg A, Goegji SD, Kirby JS, McGrath BM, Riis PT, Villumsen B, Zalik K, Jemec GBE, Hsiao JL. Shih T, et al. Among authors: thorlacius lr. Arch Dermatol Res. 2023 Sep;315(7):1863-1874. doi: 10.1007/s00403-023-02525-5. Epub 2023 Jan 21. Arch Dermatol Res. 2023. PMID: 36680593 Free PMC article. Review.
[Diagnosis and treatment of hidradenitis suppurativa].
Ring HC, Saunte DM, Riis PT, Thorlacius L, Esmann S, Jemec G. Ring HC, et al. Ugeskr Laeger. 2017 May 1;179(18):V12160904. Ugeskr Laeger. 2017. PMID: 28473026 Free article. Review. Danish.
Increased Suicide Risk in Patients with Hidradenitis Suppurativa.
Thorlacius L, Cohen AD, Gislason GH, Jemec GBE, Egeberg A. Thorlacius L, et al. J Invest Dermatol. 2018 Jan;138(1):52-57. doi: 10.1016/j.jid.2017.09.008. Epub 2017 Sep 20. J Invest Dermatol. 2018. PMID: 28942360 Free article.
Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernández-Peñas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens EP, Randell S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Thorlacius L, et al. Br J Dermatol. 2018 Mar;178(3):715-721. doi: 10.1111/bjd.16093. Epub 2018 Feb 1. Br J Dermatol. 2018. PMID: 29080368 Free PMC article.
Investigational drugs in clinical trials for Hidradenitis Suppurativa.
Theut Riis P, Thorlacius LR, Jemec GB. Theut Riis P, et al. Among authors: thorlacius lr. Expert Opin Investig Drugs. 2018 Jan;27(1):43-53. doi: 10.1080/13543784.2018.1412430. Epub 2017 Dec 4. Expert Opin Investig Drugs. 2018. PMID: 29188733 Review.
A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A, Jemec GBE; HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC). Thorlacius L, et al. Br J Dermatol. 2018 Sep;179(3):642-650. doi: 10.1111/bjd.16672. Epub 2018 Jul 5. Br J Dermatol. 2018. PMID: 29654696 Free PMC article.
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L, Garg A, Riis PT, Nielsen SM, Bettoli V, Ingram JR, Del Marmol V, Matusiak L, Pascual JC, Revuz J, Sartorius K, Tzellos T, van der Zee HH, Zouboulis CC, Saunte DM, Gottlieb AB, Christensen R, Jemec GBE. Thorlacius L, et al. Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6. Br J Dermatol. 2019. PMID: 30724351
35 results